title: HCV cirrhosis at the edge of decompensation: will paritaprevir with ritonavir, ombitasvir, dasabuvir, and ribavirin solve the need for treatment?
authors.affiliation: Centre de Recherche sur l'Inflammation (CRI), UMR 1149 Inserm, Université Paris Diderot, Service d'Hépatologie, AP-HP Hôpital Beaujon, Clichy, France. Electronic address: tarik.asselah@bjn.aphp.fr.
authors.forename: Tarik
authors.initials: T
authors.lastname: Asselah
authors.affiliation: Department of Internal Medicine, A.O. Fatebenefratelli e Oftalmico, Milan, Italy.
authors.forename: Savino
authors.initials: S
authors.lastname: Bruno
authors.affiliation: Gastroenterologia & Epatologia, Di.Bi.M.I.S., University of Palermo, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Craxi
mesh_terms: D000813:Anilides / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D002219:Carbamates / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D047028:Macrocyclic Compounds / Q000627:therapeutic use*; D008297:Male; D012254:Ribavirin / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014498:Uracil / Q000031:analogs & derivatives*
chemical_list: D000813:Anilides; D000998:Antiviral Agents; D002219:Carbamates; D047028:Macrocyclic Compounds; D013449:Sulfonamides; D012254:Ribavirin; D014498:Uracil; D019438:Ritonavir
keywords: Advanced liver disease; Direct-acting antivirals; Liver function; Portal hypertension